Evaluation of variable line-shape models and prior information in automated 1H spectroscopic imaging analysis.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 15562473)

Published in Magn Reson Med on December 01, 2004

Authors

Brian J Soher1, Andrew A Maudsley

Author Affiliations

1: University of Miami School of Medicine, MR Center (M896), P.O. Box 019132, FL 33101, USA. bsoher@med.miami.edu

Articles by these authors

Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS. Neurology (2013) 2.18

Improved spectral quality for 3D MR spectroscopic imaging using a high spatial resolution acquisition strategy. Magn Reson Imaging (2003) 1.56

Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53

GAVA: spectral simulation for in vivo MRS applications. J Magn Reson (2007) 1.29

Whole-brain proton MR spectroscopic imaging of mild-to-moderate traumatic brain injury and correlation with neuropsychological deficits. J Neurotrauma (2010) 1.23

Observation of coupled 1H metabolite resonances at long TE. Magn Reson Med (2005) 1.18

Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med (2002) 1.16

Detection and correction of frequency instabilities for volumetric 1H echo-planar spectroscopic imaging. Magn Reson Med (2005) 1.13

Volumetric proton spectroscopic imaging of mild traumatic brain injury. AJNR Am J Neuroradiol (2004) 1.12

Comparison of inversion recovery preparation schemes for lipid suppression in 1H MRSI of human brain. Magn Reson Med (2003) 1.11

Utility of multiparametric 3-T MRI for glioma characterization. Neuroradiology (2013) 1.06

Achieving sufficient spectral bandwidth for volumetric 1H echo-planar spectroscopic imaging at 4 Tesla. Magn Reson Med (2005) 0.96

Reproducibility and reliability of short-TE whole-brain MR spectroscopic imaging of human brain at 3T. Magn Reson Med (2014) 0.92

1H MRS of basal ganglia and thalamus in amyotrophic lateral sclerosis. NMR Biomed (2011) 0.91

Multisection proton MR spectroscopy for mesial temporal lobe epilepsy. AJNR Am J Neuroradiol (2002) 0.89

Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy. PLoS One (2012) 0.89

Improved reconstruction for MR spectroscopic imaging. IEEE Trans Med Imaging (2007) 0.88

Correction of local B0 shifts in 3D EPSI of the human brain at 4 T. Magn Reson Imaging (2006) 0.86

Impact of reduced k-space acquisition on pathologic detectability for volumetric MR spectroscopic imaging. J Magn Reson Imaging (2013) 0.85

A Scalable Framework For Segmenting Magnetic Resonance Images. J Signal Process Syst (2009) 0.83

Bayesian k -space-time reconstruction of MR spectroscopic imaging for enhanced resolution. IEEE Trans Med Imaging (2010) 0.82

K-Bayes reconstruction for perfusion MRI. I: concepts and application. J Digit Imaging (2009) 0.82

Magnetic resonance spectroscopic imaging reconstruction with deformable shape-intensity models. Magn Reson Med (2003) 0.81

Multivariate statistical mapping of spectroscopic imaging data. Magn Reson Med (2010) 0.80

Fast and high-resolution quantitative mapping of tissue water content with full brain coverage for clinically-driven studies. Magn Reson Imaging (2013) 0.80

Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging. Radiology (2013) 0.77

Clinical utility of magnetic resonance spectroscopy to enhance diagnosis of HIV-associated mild neurocognitive disorder. Neuropsychiatry (London) (2012) 0.75

Can MR spectroscopy ever be simple and effective? AJNR Am J Neuroradiol (2005) 0.75

Magnetic Resonance in Medicine at 30. Magn Reson Med (2014) 0.75

Sir Peter Mansfield, PhD. Radiology (2017) 0.75